Based on newly available data, researchers better understand how the Toll-like receptor 9 (TLR9) agonist Kappaproct (cobitolimod), developed by InDex Pharmaceuticals, can provide anti-inflammatory relief of the clinical symptoms of ulcerative colitis ... Read more